Image 1 (IMAGE)

Nanyang Technological University

Image 1

Caption

NTU scientists have designed ASO-1, a compound that could help to reduce an overactive immune response without impairing the body's entire immune response. The ASO-1 targets TYK2, an enzyme that plays a key role in regulating the body's immune response and has been associated with severe COVID-19.

Credit

NTU Singapore

Usage Restrictions

Use with mandatory credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.